GlassScriptPhysician profile
Yuval Hiltzik
NPI 1518102607
$262,634.07
in general payments reported to CMS, 2019-2025
39 companies · $111K in 2025
The $111K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,832 · 2020: $6,209 · 2021: $26K · 2022: $25K · 2023: $34K · 2024: $59K · 2025: $111K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $186K · Food and Beverage: $14K · Travel and Lodging: $2,958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $186,492.60 |
| Food and Beverage | $14,459.57 |
| Travel and Lodging | $2,958.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $184,134.63 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Regeneron Healthcare Solutions, INC. | $66,632.33 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $3,777.63 | 2019-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,854.98 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Electromed, INC. | $1,075.75 | 2019-2025 | Smartvest |
| Genzyme Corporation | $651.86 | 2021-2025 | |
| Mylan Specialty L.P. | $592.13 | 2019-2024 | Yupelri |
| Grifols USA, LLC | $570.25 | 2019-2025 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $485.38 | 2022-2025 | Wakix |
| Baxter Healthcare | $396.99 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Visivest Airway Clearance System |
| Advanced Respiratory, INC | $396.73 | 2019-2021 | |
| Insmed, INC. | $288.48 | 2022-2025 | Arikayce, Brinsupri |
| Vifor Pharma, INC. | $194.83 | 2024-2025 | Zemaira |
| Verona Pharma, INC. | $171.51 | 2025 | Ohtuvayre |
| Philips North America LLC | $140.32 | 2019-2025 | Vest Therapy Und |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $137.09 | 2025 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $126.03 | 2022-2023 | Aralast |
| Teva Pharmaceuticals USA, INC. | $117.42 | 2022-2023 | Airduo Digihaler |
| Amgen INC. | $116.43 | 2022-2024 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $94.40 | 2021-2024 | Uptravi |
| Merck Sharp & Dohme LLC | $89.44 | 2020-2024 | Belsomra, Recarbrio, Zerbaxa |
| Sunovion Pharmaceuticals INC. | $75.77 | 2019 | |
| Inogen, INC. | $58.73 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Nabriva Therapeutics, Plc | $52.95 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $52.64 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $45.45 | 2019-2025 | |
| Pfizer INC. | $43.05 | 2023 | |
| Ani Pharmaceuticals, INC. | $34.79 | 2023 | Purified Cortrophin Gel |
| Genentech USA, INC. | $30.47 | 2019 | |
| Ethicon INC. | $27.38 | 2022 | |
| Tactile Systems Technology INC | $24.92 | 2024 | Flexitouch Plus, Entre Plus |
| Inspire Medical Systems, INC. | $24.76 | 2025 | Inspire |
| Boston Scientific Corporation | $19.63 | 2022 | |
| Axsome Therapeutics, INC. | $19.25 | 2025 | Sunosi |
| Phadia US INC. | $18.94 | 2025 | Immunocap |
| Olympus America INC. | $16.25 | 2019 | |
| Lilly USA, LLC | $15.51 | 2025 | Zepbound |
| Allergan, INC. | $14.66 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuval Hiltzik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.